Cargando…
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
Autores principales: | Capecchi, Marco, De Leo, Pasqualina, Abbattista, Maria, Mancini, Ilaria, Agosti, Pasquale, Biganzoli, Marina, Suffritti, Chiara, Ferrari, Barbara, Lecchi, Anna, La Marca, Silvia, Padovan, Lidia, Scalambrino, Erica, Clerici, Marigrazia, Tripodi, Armando, Artoni, Andrea, Gualtierotti, Roberta, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620557/ https://www.ncbi.nlm.nih.gov/pubmed/36951158 http://dx.doi.org/10.3324/haematol.2022.282478 |
Ejemplares similares
-
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
por: Bichard, Christian, et al.
Publicado: (2022) -
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
por: Bonato, Sara, et al.
Publicado: (2021) -
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2
por: Peyvandi, Flora, et al.
Publicado: (2021) -
Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study
por: Suffritti, Chiara, et al.
Publicado: (2023)